Pharmaceutical Product Development, LLC (PPD) has appointed Patrick Bennett as executive director of laboratory operations for a new biomarker services division of its bioanalytical laboratory.
“Patrick brings more than 25 years of experience in laboratories and biomarker services,” said David Johnston, Ph.D., PPD’s executive vice president of global laboratory services. “At PPD, our bioanalytical labs provide state-of-the-art facilities and instrumentation, scientific expertise, experienced regulatory staff and capabilities in a wide variety of technologies and methods. Patrick will lead and drive strategy for comprehensive biomarker development and testing from discovery through approval of predictive medicine biomarkers for both large and small molecule therapeutics.”
With facilities in Richmond, Va., and Middleton, Wis., PPD’s bioanalytical labs provide accurate, high-quality results across all phases of drug development and commercialization delivered in a good laboratory practice (GLP)-compliant setting. Services include customized biomarker measurement; comprehensive, state-of-the-art assay development; method development, validation, transfer and sample analysis in multiple biological species and matrices; validated methods to quantitatively measure all types of compounds; chromatography; immunochemistry; and metabolite identification.
Most recently, Bennett was global strategic marketing director for pharma/biopharma life sciences mass spectrometry at Thermo Fisher Scientific, where he led efforts to develop, manage and implement marketing strategies. Before Thermo Fisher, he served as vice president of business development and marketing and executive laboratory director at Tandem Labs, where he managed scientific and regulatory leadership activities.
He holds a bachelor’s in toxicology and master’s in pharmacology from St. John’s University and received his Master of Business Administration in marketing from Syracuse University.